I haven't seen a formal presentation on the data. All I know if Merck/Ariad are NOT going forward with it - and - instead - are using MK-646 and Rida combo (which is showing good results, I believe). Would like to have seen the poster presentation for the data at ASCO except it was never publicly released.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.